MedTrace Logo

Pilot Study of Cardiac MR in Patients With Muscular Dystrophy

NCT02921321 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-12-11

No results posted yet for this study

Summary

Muscular Dystrophy can affect the skeletal muscles and also the heart and breathing muscles, causing significant morbidity and mortality. As patients are now living longer, treatment of muscular dystrophies involves drugs that help improve heart function. However, better types of heart imaging studies are needed to understand how these treatments work. Researchers want to improve heart imaging to identify earlier indicators of heart dysfunction in muscular dystrophy patients and how these are changed by medical treatment. The new imaging indicators will also help identify candidates for entry into future clinical trials.

Conditions

  • Muscular Dystrophies
  • Cardiac Fibrosis
  • Genetic Diseases, Inborn
  • Musculoskeletal Diseases

Sponsors & Collaborators

  • Children's National Research Institute

    lead OTHER

Principal Investigators

  • Christopher Spurney, MD · Children's National Research Institute

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2024-12-09
Completion
2024-12-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02921321 on ClinicalTrials.gov